trial
as of 2026-07-01Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia
NCTId NCT00176423
at a glance
Phase 4 · Completed
Enrollment 117 (actual)
Sponsored by University of Maryland, Baltimore County
Primary completion 2006-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
117 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2002-05
Primary completion
2006-12
Eligibility
ALL · 18 Years · 60 Years
Interventions & indications
Sponsors
University of Maryland, Baltimore CountyLead Sponsor
Stanley Medical Research InstituteCollaborator
Ortho-McNeil Neurologics, Inc.Collaborator
Investigators
1
Robert C Smith, M.D., Ph.DPrincipal Investigator
Sites
1 total
Baltimore, United States
Facts & assertions
4 sourced
Enrollment
117
Phase
PHASE4
Primary Completion Date
2006-12
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
investigator